{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T16:52:03Z","timestamp":1780073523215,"version":"3.54.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,3,15]],"date-time":"2013-03-15T00:00:00Z","timestamp":1363305600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1743-422x-10-87","type":"journal-article","created":{"date-parts":[[2013,3,15]],"date-time":"2013-03-15T20:11:53Z","timestamp":1363378313000},"source":"Crossref","is-referenced-by-count":9,"title":["Epidemiological, virological and clinical characteristics of HBV infection in 223 HIV co-infected patients: a French multi-centre collaborative study"],"prefix":"10.1186","volume":"10","author":[{"given":"Vincent","family":"Thibault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Gaudy-Graffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Colson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00ebl","family":"Gozlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Schnepf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Trimoulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coralie","family":"Pallier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Saune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Branger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Coste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francoise Roudot","family":"Thoraval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,15]]},"reference":[{"key":"2067_CR1","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/01.aids.0000163936.99401.fe","volume":"19","author":"D Konopnicki","year":"2005","unstructured":"Konopnicki D, Mocroft A, de Wit S, Antunes F, Ledergerber B, Katlama C, Zilmer K, Vella S, Kirk O, Lundgren JD: Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. Aids 2005, 19: 593-601. 10.1097\/01.aids.0000163936.99401.fe","journal-title":"Aids"},{"key":"2067_CR2","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1097\/QAD.0b013e3282f8b46f","volume":"22","author":"V Soriano","year":"2008","unstructured":"Soriano V, Puoti M, Peters M, Benhamou Y, Sulkowski M, Zoulim F, Mauss S, Rockstroh J: Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel. Aids 2008, 22: 1399-1410. 10.1097\/QAD.0b013e3282f8b46f","journal-title":"Aids"},{"key":"2067_CR3","doi-asserted-by":"publisher","first-page":"705","DOI":"10.7326\/0003-4819-125-9-199611010-00001","volume":"125","author":"Y Benhamou","year":"1996","unstructured":"Benhamou Y, Katlama C, Lunel F, Coutellier A, Dohin E, Hamm N, Tubiana R, Herson S, Poynard T, Opolon P: Effects of lamivudine on replication of hepatitis B virus in HIV-infected men. Ann Intern Med 1996, 125: 705-712.","journal-title":"Ann Intern Med"},{"issue":"Suppl 1","key":"2067_CR4","doi-asserted-by":"publisher","first-page":"i47","DOI":"10.1136\/gutjnl-2012-302062","volume":"61","author":"K Lacombe","year":"2012","unstructured":"Lacombe K, Rockstroh J: HIV and viral hepatitis coinfections: advances and challenges. Gut 2012,61(Suppl 1):i47-58. 10.1136\/gutjnl-2012-302062","journal-title":"Gut"},{"key":"2067_CR5","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1365-2893.2005.00692.x","volume":"13","author":"P Halfon","year":"2006","unstructured":"Halfon P, Bourliere M, Pol S, Benhamou Y, Ouzan D, Rotily M, Khiri H, Renou C, Penaranda G, Saadoun D: Multicentre study of hepatitis B virus genotypes in France: correlation with liver fibrosis and hepatitis B e antigen status. J Viral Hepat 2006, 13: 329-335. 10.1111\/j.1365-2893.2005.00692.x","journal-title":"J Viral Hepat"},{"key":"2067_CR6","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1089\/088922203322280874","volume":"19","author":"M Perez-Olmeda","year":"2003","unstructured":"Perez-Olmeda M, Nunez M, Garcia-Samaniego J, Rios P, Gonzalez-Lahoz J, Soriano V: Distribution of hepatitis B virus genotypes in HIV-infected patients with chronic hepatitis B: therapeutic implications. AIDS Res Hum Retroviruses 2003, 19: 657-659. 10.1089\/088922203322280874","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2067_CR7","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/S0399-8320(07)78341-0","volume":"31","author":"P Trimoulet","year":"2007","unstructured":"Trimoulet P, Boutonnet M, Winnock M, Faure M, Loko MA, De Ledinghen V, Bernard PH, Castera L, Foucher J, Dupon M: Hepatitis B virus genotypes: a retrospective survey in Southwestern France, 1999\u20132004. Gastroenterol Clin Biol 2007, 31: 1088-1094. 10.1016\/S0399-8320(07)78341-0","journal-title":"Gastroenterol Clin Biol"},{"key":"2067_CR8","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/j.1365-2893.2005.00712.x","volume":"13","author":"F Zoulim","year":"2006","unstructured":"Zoulim F, Poynard T, Degos F, Slama A, El Hasnaoui A, Blin P, Mercier F, Deny P, Landais P, Parvaz P, Trepo C: A prospective study of the evolution of lamivudine resistance mutations in patients with chronic hepatitis B treated with lamivudine. J Viral Hepat 2006, 13: 278-288. 10.1111\/j.1365-2893.2005.00712.x","journal-title":"J Viral Hepat"},{"key":"2067_CR9","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jcv.2009.07.024","volume":"46","author":"MA Balinska","year":"2009","unstructured":"Balinska MA: Hepatitis B vaccination and French Society ten years after the suspension of the vaccination campaign: how should we raise infant immunization coverage rates? J Clin Virol 2009, 46: 202-205. 10.1016\/j.jcv.2009.07.024","journal-title":"J Clin Virol"},{"key":"2067_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2807\/ese.13.22.18888-en","volume":"13","author":"C Larsen","year":"2008","unstructured":"Larsen C, Pialoux G, Salmon D, Antona D, Le Strat Y, Piroth L, Pol S, Rosenthal E, Neau D, Semaille C, Delarocque Astagneau E: Prevalence of hepatitis C and hepatitis B infection in the HIV-infected population of France, 2004. Euro Surveill 2008, 13: 1-4.","journal-title":"Euro Surveill"},{"key":"2067_CR11","volume-title":"French Experts group's recommendations for medical management of HIV infection highlights and recommendations","author":"P Yeni","year":"2006","unstructured":"Yeni P: French Experts group's recommendations for medical management of HIV infection highlights and recommendations. 2006. [ http:\/\/www.sante.gouv.fr\/IMG\/pdf\/rapport_experts_angl_2006.pdf ] []"},{"key":"2067_CR12","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.jhep.2003.09.022","volume":"39","author":"JP Villeneuve","year":"2003","unstructured":"Villeneuve JP, Durantel D, Durantel S, Westland C, Xiong S, Brosgart CL, Gibbs CS, Parvaz P, Werle B, Trepo C, Zoulim F: Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient. J Hepatol 2003, 39: 1085-1089. 10.1016\/j.jhep.2003.09.022","journal-title":"J Hepatol"},{"key":"2067_CR13","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1093\/molbev\/msm092","volume":"24","author":"K Tamura","year":"2007","unstructured":"Tamura K, Dudley J, Nei M, Kumar S: MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007, 24: 1596-1599. 10.1093\/molbev\/msm092","journal-title":"Mol Biol Evol"},{"key":"2067_CR14","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.jhep.2009.01.022","volume":"50","author":"J Bottero","year":"2009","unstructured":"Bottero J, Lacombe K, Guechot J, Serfaty L, Miailhes P, Bonnard P, Wendum D, Molina JM, Lascoux-Combe C, Girard PM: Performance of 11 biomarkers for liver fibrosis assessment in HIV\/HBV co-infected patients. J Hepatol 2009, 50: 1074-1083. 10.1016\/j.jhep.2009.01.022","journal-title":"J Hepatol"},{"key":"2067_CR15","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.jhep.2005.03.003","volume":"42","author":"A Alberti","year":"2005","unstructured":"Alberti A, Clumeck N, Collins S, Gerlich W, Lundgren J, Palu G, Reiss P, Thiebaut R, Weiland O, Yazdanpanah Y, Zeuzem S: Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients. J Hepatol 2005, 42: 615-624. 10.1016\/j.jhep.2005.03.003","journal-title":"J Hepatol"},{"key":"2067_CR16","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jhep.2008.10.001","volume":"50","author":"European Association For The Study Of The L","year":"2009","unstructured":"European Association For The Study Of The L: EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol 2009, 50: 227-242. 10.1016\/j.jhep.2008.10.001","journal-title":"J Hepatol"},{"key":"2067_CR17","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/hep.23190","volume":"50","author":"AS Lok","year":"2009","unstructured":"Lok AS, McMahon BJ: Chronic hepatitis B: update 2009. Hepatology 2009, 50: 661-662. 10.1002\/hep.23190","journal-title":"Hepatology"},{"key":"2067_CR18","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1468-1293.2007.00535.x","volume":"9","author":"JK Rockstroh","year":"2008","unstructured":"Rockstroh JK, Bhagani S, Benhamou Y, Bruno R, Mauss S, Peters L, Puoti M, Soriano V, Tural C: European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults. HIV Med 2008, 9: 82-88. 10.1111\/j.1468-1293.2007.00535.x","journal-title":"HIV Med"},{"key":"2067_CR19","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1097\/QAD.0b013e32832e463a","volume":"23","author":"CJ Hoffmann","year":"2009","unstructured":"Hoffmann CJ, Seaberg EC, Young S, Witt MD, D'Acunto K, Phair J, Thio CL: Hepatitis B and long-term HIV outcomes in coinfected HAART recipients. Aids 2009, 23: 1881-1889. 10.1097\/QAD.0b013e32832e463a","journal-title":"Aids"},{"key":"2067_CR20","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1093\/jac\/dkp479","volume":"65","author":"V Soriano","year":"2010","unstructured":"Soriano V, Mocroft A, Peters L, Rockstroh J, Antunes F, Kirkby N, de Wit S, Monforte A, Flisiak R, Lundgren J: Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe. J Antimicrob Chemother 2010, 65: 548-555. 10.1093\/jac\/dkp479","journal-title":"J Antimicrob Chemother"},{"key":"2067_CR21","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1086\/649885","volume":"50","author":"HM Chun","year":"2010","unstructured":"Chun HM, Fieberg AM, Hullsiek KH, Lifson AR, Crum-Cianflone NF, Weintrob AC, Ganesan A, Barthel RV, Bradley WP, Agan BK, Landrum ML: Epidemiology of Hepatitis B virus infection in a US cohort of HIV-infected individuals during the past 20\u00a0years. Clin Infect Dis 2010, 50: 426-436. 10.1086\/649885","journal-title":"Clin Infect Dis"},{"key":"2067_CR22","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/01.aids.0000200537.86984.0e","volume":"20","author":"K Lacombe","year":"2006","unstructured":"Lacombe K, Massari V, Girard PM, Serfaty L, Gozlan J, Pialoux G, Mialhes P, Molina JM, Lascoux-Combe C, Wendum D: Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIV. Aids 2006, 20: 419-427. 10.1097\/01.aids.0000200537.86984.0e","journal-title":"Aids"},{"key":"2067_CR23","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jhep.2006.03.007","volume":"45","author":"JP Zarski","year":"2006","unstructured":"Zarski JP, Marcellin P, Leroy V, Trepo C, Samuel D, Ganne-Carrie N, Barange K, Canva V, Doffoel M, Cales P: Characteristics of patients with chronic hepatitis B in France: predominant frequency of HBe antigen negative cases. J Hepatol 2006, 45: 355-360. 10.1016\/j.jhep.2006.03.007","journal-title":"J Hepatol"},{"key":"2067_CR24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1099\/0022-1317-81-1-67","volume":"81","author":"L Stuyver","year":"2000","unstructured":"Stuyver L, De Gendt S, Van Geyt C, Zoulim F, Fried M, Schinazi RF, Rossau R: A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol 2000, 81: 67-74.","journal-title":"J Gen Virol"},{"key":"2067_CR25","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1053\/jhep.2002.32096","volume":"35","author":"H Kato","year":"2002","unstructured":"Kato H, Orito E, Gish RG, Bzowej N, Newsom M, Sugauchi F, Suzuki S, Ueda R, Miyakawa Y, Mizokami M: Hepatitis B e antigen in sera from individuals infected with hepatitis B virus of genotype G. Hepatology 2002, 35: 922-929. 10.1053\/jhep.2002.32096","journal-title":"Hepatology"},{"key":"2067_CR26","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1002\/hep.510300525","volume":"30","author":"Y Benhamou","year":"1999","unstructured":"Benhamou Y, Bochet M, Thibault V, Di Martino V, Caumes E, Bricaire F, Opolon P, Katlama C, Poynard T: Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients. Hepatology 1999, 30: 1302-1306. 10.1002\/hep.510300525","journal-title":"Hepatology"},{"key":"2067_CR27","doi-asserted-by":"publisher","first-page":"11833","DOI":"10.1128\/JVI.77.21.11833-11841.2003","volume":"77","author":"WE Delaney","year":"2003","unstructured":"Delaney WE, Yang H, Westland CE, Das K, Arnold E, Gibbs CS, Miller MD, Xiong S: The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitro. J Virol 2003, 77: 11833-11841. 10.1128\/JVI.77.21.11833-11841.2003","journal-title":"J Virol"},{"key":"2067_CR28","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1086\/520752","volume":"45","author":"P Miailhes","year":"2007","unstructured":"Miailhes P, Trabaud MA, Pradat P, Lebouche B, Chevallier M, Chevallier P, Zoulim F, Trepo C: Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion. Clin Infect Dis 2007, 45: 624-632. 10.1086\/520752","journal-title":"Clin Infect Dis"},{"key":"2067_CR29","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.23246","volume":"51","author":"F van Bommel","year":"2010","unstructured":"van Bommel F, de Man RA, Wedemeyer H, Deterding K, Petersen J, Buggisch P, Erhardt A, Huppe D, Stein K, Trojan J: Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside\/nucleotide analogues. Hepatology 2010, 51: 73-80. 10.1002\/hep.23246","journal-title":"Hepatology"},{"key":"2067_CR30","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/hep.22295","volume":"48","author":"N Warner","year":"2008","unstructured":"Warner N, Locarnini S: The antiviral drug selected hepatitis B virus rtA181T\/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound. Hepatology 2008, 48: 88-98. 10.1002\/hep.22295","journal-title":"Hepatology"},{"key":"2067_CR31","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1128\/AAC.00239-06","volume":"50","author":"H Yatsuji","year":"2006","unstructured":"Yatsuji H, Noguchi C, Hiraga N, Mori N, Tsuge M, Imamura M, Takahashi S, Iwao E, Fujimoto Y, Ochi H: Emergence of a novel lamivudine-resistant hepatitis B virus variant with a substitution outside the YMDD motif. Antimicrob Agents Chemother 2006, 50: 3867-3874. 10.1128\/AAC.00239-06","journal-title":"Antimicrob Agents Chemother"},{"key":"2067_CR32","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1053\/j.gastro.2010.08.045","volume":"139","author":"TE de Vries-Sluijs","year":"2010","unstructured":"de Vries-Sluijs TE, Reijnders JG, Hansen BE, Zaaijer HL, Prins JM, Pas SD, Schutten M, Hoepelman AI, Richter C, Mulder JW: Long-term therapy with tenofovir is effective for patients co-infected with human immunodeficiency virus and hepatitis B virus. Gastroenterology 2010, 139: 1934-1941. 10.1053\/j.gastro.2010.08.045","journal-title":"Gastroenterology"},{"key":"2067_CR33","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1053\/j.gastro.2010.10.011","volume":"140","author":"EJ Heathcote","year":"2011","unstructured":"Heathcote EJ, Marcellin P, Buti M, Gane E, De Man RA, Krastev Z, Germanidis G, Lee SS, Flisiak R, Kaita K: Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B. Gastroenterology 2011, 140: 132-143. 10.1053\/j.gastro.2010.10.011","journal-title":"Gastroenterology"},{"key":"2067_CR34","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1365-2893.2007.00938.x","volume":"15","author":"HL Zaaijer","year":"2008","unstructured":"Zaaijer HL, Bouter S, Boot HJ: Substitution rate of the hepatitis B virus surface gene. J Viral Hepat 2008, 15: 239-245. 10.1111\/j.1365-2893.2007.00938.x","journal-title":"J Viral Hepat"},{"key":"2067_CR35","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1177\/135965350701200801","volume":"12","author":"AM Roque-Afonso","year":"2007","unstructured":"Roque-Afonso AM, Ferey MP, Ly TD, Graube A, Costa-Faria L, Samuel D, Dussaix E: Viral and clinical factors associated with surface gene variants among hepatitis B virus carriers. Antivir Ther 2007, 12: 1255-1263.","journal-title":"Antivir Ther"},{"key":"2067_CR36","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/QAI.0b013e318154bd89","volume":"46","author":"J Sheldon","year":"2007","unstructured":"Sheldon J, Ramos B, Garcia-Samaniego J, Rios P, Bartholomeusz A, Romero M, Locarnini S, Zoulim F, Soriano V: Selection of hepatitis B virus (HBV) vaccine escape mutants in HBV-infected and HBV\/HIV-coinfected patients failing antiretroviral drugs with anti-HBV activity. J Acquir Immune Defic Syndr 2007, 46: 279-282. 10.1097\/QAI.0b013e318154bd89","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2067_CR37","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/QAD.0b013e32832cd99e","volume":"24","author":"ML Landrum","year":"2010","unstructured":"Landrum ML, Hullsiek KH, Ganesan A, Weintrob AC, Crum-Cianflone NF, Barthel RV, O'Connell RJ, Fieberg A, Chun HM, Marconi VC: Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individuals. Aids 2010, 24: 545-555. 10.1097\/QAD.0b013e32832cd99e","journal-title":"Aids"},{"key":"2067_CR38","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1086\/512367","volume":"44","author":"MK Jain","year":"2007","unstructured":"Jain MK, Opio CK, Osuagwu CC, Pillai R, Keiser P, Lee WM: Do HIV care providers appropriately manage hepatitis B in coinfected patients treated with antiretroviral therapy? Clin Infect Dis 2007, 44: 996-1000. 10.1086\/512367","journal-title":"Clin Infect Dis"},{"key":"2067_CR39","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1002\/hep.22884","volume":"49","author":"CJ Chen","year":"2009","unstructured":"Chen CJ, Yang HI, Iloeje UH: Hepatitis B virus DNA levels and outcomes in chronic hepatitis B. Hepatology 2009, 49: S72-84. 10.1002\/hep.22884","journal-title":"Hepatology"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-10-87.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1743-422X-10-87\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-10-87.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T09:25:32Z","timestamp":1688117132000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-10-87"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,15]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2067"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-10-87","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,15]]},"article-number":"87"}}